BioTelemetry Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 30.09. In total, the insiders bought 4.36M and sold 397.44K BEAT shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
30.09
Buy 4.36M shares
Sell 397.44K shares
69% Buy Activity
Negligible or No Correlation
Buy Signal Medium Confidence
Apr 16, 2026

Analysis Breakdown:

  • Supported by a positive Insider Power Score of 30.09.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Feb 14, 2025
Buy
Common Stock
P-Purchase
Ferrari Richard
Director
Director 29 412
Value: $50.0K
Feb 14, 2025
Buy
Common Stock
P-Purchase
Cruickshank Tim
CFO
C-Suite Officer 17 647
Value: $30.0K
Feb 14, 2025
Buy
Common Stock
P-Purchase
Cruickshank Tim
CFO
C-Suite Officer 17 647
Value: $30.0K
Feb 14, 2025
Buy
Common Stock
P-Purchase
Ferrari Richard
Director
Director 29 412
Value: $50.0K
Sep 25, 2024
Buy
Common Stock (right to buy)
A-Award
Cruickshank Tim
CFO
C-Suite Officer 400 000
Value: $912.0K
Sep 25, 2024
Buy
Common Stock (right to buy)
A-Award
Cruickshank Tim
CFO
C-Suite Officer 400 000
Value: $912.0K
Sep 09, 2024
Buy
Common Stock
J-Other
Cruickshank Tim
Officer
Officer 0
Value: $0
Sep 09, 2024
Buy
Common Stock
J-Other
Cruickshank Tim
Officer
Officer 0
Value: $0
Sep 06, 2024
Sell
Common Stock
S-Sale
De Urioste George
Director
Director 1 674
Value: $4K
Sep 06, 2024
Sell
Common Stock
S-Sale
De Urioste George
Director
Director 1 674
Value: $4K
Aug 30, 2024
Sell
Common Stock
S-Sale
De Urioste George
Director
Director 5 500
Value: $12.7K
Aug 30, 2024
Sell
Common Stock
S-Sale
De Urioste George
Director
Director 5 500
Value: $12.7K
Aug 27, 2024
Sell
Common Stock
S-Sale
De Urioste George
Director
Director 2 194
Value: $5K
Aug 27, 2024
Sell
Common Stock
S-Sale
De Urioste George
Director
Director 2 194
Value: $5K
Aug 26, 2024
Sell
Common Stock
S-Sale
De Urioste George
Director
Director 300
Value: $714
Aug 26, 2024
Sell
Common Stock
S-Sale
De Urioste George
Director
Director 300
Value: $714
Aug 23, 2024
Sell
Common Stock
S-Sale
De Urioste George
Director
Director 2 500
Value: $6K
Aug 23, 2024
Sell
Common Stock
S-Sale
De Urioste George
Director
Director 2 500
Value: $6K
Jun 12, 2024
Buy
Common Stock
A-Award
Nelson Kenneth Warwick Iii
Director
Director 33 185
Value: $75.0K
Jun 12, 2024
Buy
Common Stock
A-Award
Jaff Michael R
Director
Director 33 185
Value: $75.0K
Jun 12, 2024
Buy
Common Stock
A-Award
Elfrink Willem
Director
Director 33 185
Value: $75.0K
Jun 12, 2024
Buy
Common Stock
A-Award
Strome Mark E
10 Percent Owner
10% Owner 33 185
Value: $75.0K
Jun 12, 2024
Buy
Common Stock
A-Award
De Urioste George
Director
Director 33 185
Value: $75.0K
Jun 12, 2024
Buy
Common Stock
A-Award
Ferrari Richard
Director
Director 44 247
Value: $100.0K
Jun 12, 2024
Buy
Common Stock
A-Award
Ortigas-wedekind Marga
Director
Director 33 185
Value: $75.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT BIOTELEMETRY
BioTelemetry
HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE